Thanks Charlie and the rest who have shown an interest in this stock lately. Your information is valuable. At this stage of the game, Valence doesn't have to make a dime to be a $30 stock. Any announcements of OEM agreements (like the Red Chip noted), production success, etc., will certainly "charge" the stock price of Valence! Yes, in the big picture of things, it is a crap shoot. But, would you rather shoot craps on Valence's enormous price appreciation potential, or invest in an AT&T and watch the price of your stock depreciate over several years? After all, Valence doesn't have to deal with the FDA, Microsoft or Intel? What else could you ask for?? They have alliances, they have a plant where they are agressively pursuing commercial production, they are working on OEM (I assume), they fit into Peter Lynch's motto, "only invest in companies that make products you can understand", assuming we all know what a battery is.
As every day passes, I am encouraged at the potential of Valence. The recent weakness in the stock price is confusing (especially if they got a good write-up in the Red Chip report), but I take solice in the fact that it continues to be on very low volume. The BIG BOYS are holding this one. If anything, they may be the ones manipulating the price to get it lower so they can load up on more for cheap.
Keep up the news postings. Whether it be related to Valence, UltraLife, AER or anyone else, or relates in any way whatsoever to Valence's business, please post. The Power is in SHARED INFORMATION! |
